Logo image of MHLA

MAIDEN HOLDING LTD - MHLD 6 5/8 06/14/46 (MHLA) Stock Fundamental Analysis

NYSE:MHLA - New York Stock Exchange, Inc. - US5602923022 - Currency: USD

14.4  0 (0%)

Fundamental Rating

0

Taking everything into account, MHLA scores 0 out of 10 in our fundamental rating. MHLA was compared to 144 industry peers in the Insurance industry. MHLA may be in some trouble as it scores bad on both profitability and health. MHLA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MHLA had negative earnings in the past year.
MHLA had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MHLA reported negative net income in multiple years.
MHLA had a negative operating cash flow in each of the past 5 years.
MHLA Yearly Net Income VS EBIT VS OCF VS FCFMHLA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

1.2 Ratios

MHLA has a Return On Assets of -4.58%. This is amonst the worse of the industry: MHLA underperforms 92.31% of its industry peers.
The Return On Equity of MHLA (-30.63%) is worse than 93.01% of its industry peers.
Industry RankSector Rank
ROA -4.58%
ROE -30.63%
ROIC N/A
ROA(3y)1.82%
ROA(5y)0.89%
ROE(3y)11.41%
ROE(5y)4.63%
ROIC(3y)N/A
ROIC(5y)N/A
MHLA Yearly ROA, ROE, ROICMHLA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MHLA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MHLA Yearly Profit, Operating, Gross MarginsMHLA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100

More info and screens

0

2. Health

2.1 Basic Checks

MHLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MHLA has less shares outstanding
The number of shares outstanding for MHLA has been increased compared to 5 years ago.
MHLA has a worse debt/assets ratio than last year.
MHLA Yearly Shares OutstandingMHLA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
MHLA Yearly Total Debt VS Total AssetsMHLA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

A Debt/Equity ratio of 1.22 is on the high side and indicates that MHLA has dependencies on debt financing.
The Debt to Equity ratio of MHLA (1.22) is worse than 88.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.5%
MHLA Yearly LT Debt VS Equity VS FCFMHLA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MHLA Yearly Current Assets VS Current LiabilitesMHLA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for MHLA have decreased strongly by -369.83% in the last year.
The Revenue has been growing slightly by 4.74% in the past year.
MHLA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -47.89% yearly.
EPS 1Y (TTM)-369.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)4.74%
Revenue growth 3Y-23.55%
Revenue growth 5Y-47.89%
Sales Q2Q%-15.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHLA Yearly Revenue VS EstimatesMHLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B
MHLA Yearly EPS VS EstimatesMHLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MHLA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MHLA Price Earnings VS Forward Price EarningsMHLA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MHLA Per share dataMHLA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.50%, MHLA is a good candidate for dividend investing.
MHLA's Dividend Yield is rather good when compared to the industry average which is at 3.17. MHLA pays more dividend than 100.00% of the companies in the same industry.
MHLA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 11.5%

5.2 History

MHLA has paid a dividend for at least 10 years, which is a reliable track record.
As MHLA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years7
MHLA Yearly Dividends per shareMHLA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
MHLA Yearly Income VS Free CF VS DividendMHLA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

More info and screens

MAIDEN HOLDING LTD - MHLD 6 5/8 06/14/46

NYSE:MHLA (3/7/2025, 8:04:00 PM)

14.4

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-17 2025-03-17
Inst Owners33.42%
Inst Owner ChangeN/A
Ins Owners21.28%
Ins Owner ChangeN/A
Market Cap1.43B
Analysts43.33
Price TargetN/A
Short Float %0.01%
Short Ratio0.48
Dividend
Industry RankSector Rank
Dividend Yield 11.5%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years7
Ex-Date02-28 2025-02-28 (0.4140625)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18.02
P/FCF N/A
P/OCF N/A
P/B 6.87
P/tB 6.87
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.8
BVpS2.1
TBVpS2.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.58%
ROE -30.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.82%
ROA(5y)0.89%
ROE(3y)11.41%
ROE(5y)4.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC8.5%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-369.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.74%
Revenue growth 3Y-23.55%
Revenue growth 5Y-47.89%
Sales Q2Q%-15.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.35%
OCF growth 3YN/A
OCF growth 5YN/A